EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: February 2015

World Class Drug Discovery Team Launches New Company to Tackle Chronic Respiratory Disease

February 11, 2015

Brighton, Sussex, February 11th 2015 – ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has

Read »

Apellis Pharmaceuticals Enters Clinical Testing Phase in its Age-Related Macular Degeneration Program

February 10, 2015

Crestwood, KY – February 10th 2015 – Apellis Pharmaceuticals, Inc. announced that it has begun the Phase I clinical trial of its drug compound APL-2

Read »

EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: February 2015

World Class Drug Discovery Team Launches New Company to Tackle Chronic Respiratory Disease

Apellis Pharmaceuticals Enters Clinical Testing Phase in its Age-Related Macular Degeneration Program

Categories

Archives